companydata.dkcompanydata.dk

MS-OMICS ApS: Financial statements 2021

CVR: 36070374

Source: annual report 2021, Danish Business Authority

01/01/202131/12/2021

MS-OMICS ApS (CVR 36070374) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 7,341,503 and a net result of DKK 419,374 compared with DKK -1,267,307 the year before. That is an increase of 112.6% compared with the year before. Equity in the 2021 report amounted to DKK 70,015. The solvency ratio was 0.6%. The company had 10 employees in the financial year.

Gross Profit
DKK 7,341,503
Profit/Loss
DKK 419,374
Equity
DKK 70,015
Total Assets
DKK 10,961,962
Employees
10

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2021-7.3 mio.419 t.70 t.10
2020-3.5 mio.-1.3 mio.-349 t.7
2019-2.6 mio.-45 t.418 t.5
2018-1.3 mio.-945 t.463 t.5
2017-1 mio.146 t.-591 t.3

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like MS-OMICS ApS

Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.

Try the lead list generator

Events in 2021

MS-OMICS ApS: The 2020 annual report is outMay 17, 2021

MS-OMICS ApS has published its annual report for 2020. Gross profit came to DKK 3,453,855, and the net result was DKK -1,267,307.

About MS-OMICS ApS

MS-OMICS ApS is a Danish company of the type Anpartsselskab based in Vedbæk, founded in 2014. The company is registered under the industry Anden teknisk rådgivning. The management consists of Anders Mohr Christensen. The company is owned by Clinical-Microbiomics A/S. The company has 6 employees (2018). In 2025, the company reported a gross profit of DKK 16,799,037 and a net result of DKK 806,990 compared with DKK 2,341,741 the year before. Equity in the 2025 report amounted to DKK 3,170,348.

Source: annual report 2025, Danish Business Authority